In a commentary in JAMA, hospitalist Alec B. O’Connor calls for more stringent Federal guidelines governing the approval of potential new drugs. He says the FDA should require studies comparing the effectiveness and safety of a new drug to an established first-line drug when considering a drug for approval.
Physician calls for more rigorous standards for drugs up for FDA approval
March 14th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.